Use of illicit substances and violent behaviour in psychotic disorders: two nationwide case-control studies and meta-analyses
Jelle Lamsma, Wiepke Cahn, Seena Fazel, Group And Neden Investigators
Psychological Medicine August 29, 2019 DOI: 10.1017/s0033291719002125 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Meta-analysis of two cross-sectional samples Peer reviewed |
|---|---|
| Sample size | 1,792 |
| Population | Individuals with psychotic disorders in the Netherlands and the United Kingdom |
| Topics | Cannabis Addiction |
| Keywords | Odds ratio Confidence interval Poison control Hallucinogen Meta-analysis Logistic regression |
| Citations | 48 |
| Key findings | Daily and nondaily use of various illicit substances, including cannabis, stimulants, depressants, and hallucinogens, are associated with increased odds of violence in people with psychotic disorders. |
Abstract
Abstract Background Substance use disorder explains much of the excess risk of violent behaviour in psychotic disorders. However, it is unclear to what extent the pharmacological properties and subthreshold use of illicit substances are associated with violence.
Methods: Individuals with psychotic disorders were recruited for two nationwide projects: GROUP ( N = 871) in the Netherlands and NEDEN ( N = 921) in the United Kingdom. Substance use and violent behaviour were assessed with standardized instruments and multiple sources of information. First, we used logistic regression models to estimate the associations of daily and nondaily use with violence for cannabis, stimulants, depressants and hallucinogens in the GROUP and NEDEN samples separately. Adjustments were made for age, sex and educational level. We then combined the results in random-effects meta-analyses.
Results: Daily use, compared with nondaily or no use, and nondaily use, compared with no use, increased the pooled odds of violence in people with psychotic disorders for all substance categories. The increases were significant for daily use of cannabis [pooled odds ratio (pOR) 1.6, 95% confidence interval (CI) 1.2–2.0), stimulants (pOR 2.8, 95% CI 1.7–4.5) and depressants (pOR 2.2, 95% CI 1.1–4.5), and nondaily use of stimulants (pOR 1.6, 95% CI 1.2–2.0) and hallucinogens (pOR 1.5, 95% CI 1.1–2.1). Daily use of hallucinogens, which could only be analysed in the NEDEN sample, significantly increased the risk of violence (adjusted odds ratio 3.3, 95% CI 1.2–9.3).
Conclusions: Strategies to prevent violent behaviour in psychotic disorders should target any substance use.
Comparable studies
Other systematic reviews and meta-analyses on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Effects of cannabis use on outcomes of psychotic disorders: systematic review People with psychotic disorders, as examined in 13 longitudinal studies | 2008 | Systematic review | |
| The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample Patients with established schizophrenia (meta-analysis: 572) and patients with... | 2010 | Meta-analysis and cross-sectional observational study | n = 700 |
| Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review | 2020 | Systematic review | |
| Neuroimaging in cannabis use: a systematic review of the literature Cannabis users and controls in neuroimaging studies | 2009 | Systematic review | |
| Human Laboratory Studies on Cannabinoids and Psychosis. Healthy human subjects and individuals with schizophrenia | 2016 | Systematic review |
Citations in the library
Cited by 6
- Ethics and ego dissolution: the case of psilocybin Journal of Medical Ethics May 27, 2020
- Early onset of cannabis use and violent behavior in psychosis European Psychiatry 2020
- Moral Considerations and the Experience of Ego Dissolution: Insights from Psilocybin Asian Journal of Ethics in Health and Medicine 2025
- Contextualizing Violence Risk Associated With Hallucinogens FOCUS: The Journal of Lifelong Learning in Psychiatry 2026
- Assessing Cannabis Use in People with Psychosis Cannabis and Cannabinoid Research February 1, 2024
and 1 more in the library
Cites 3
- Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants Frontiers in Neuroscience April 19, 2016
- Novel psychoactive substances: types, mechanisms of action, and effects BMJ January 25, 2017
- The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study The Lancet Psychiatry May 1, 2019